SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-007364
Filing Date
2019-03-12
Accepted
2019-03-12 16:30:15
Documents
8
Period of Report
2019-04-24
Effectiveness Date
2019-03-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A cbm-def14a_20190424.htm DEF 14A 1793120
2 GRAPHIC g5djc3htcf1o000004.jpg GRAPHIC 2725
3 GRAPHIC g5djc3htcf1o000002.jpg GRAPHIC 2924
4 GRAPHIC g5djc3htcf1o000003.jpg GRAPHIC 3858
5 GRAPHIC g5djc3htcf1o000001.jpg GRAPHIC 3858
6 GRAPHIC g5djc3htcf1o000007.jpg GRAPHIC 44681
7 GRAPHIC g5djc3htcf1o000006.jpg GRAPHIC 43995
8 GRAPHIC g5djc3htcf1o000005.jpg GRAPHIC 3249
  Complete submission text file 0001564590-19-007364.txt   1940164
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

IRS No.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10638 | Film No.: 19675463
SIC: 2834 Pharmaceutical Preparations